Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cavitation Technologies (CVAT) Cash & Equivalents (2016 - 2025)

Cavitation Technologies' Cash & Equivalents history spans 16 years, with the latest figure at $31000.0 for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 95.45% to $31000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $31000.0, a 95.45% decrease, with the full-year FY2025 number at $249000.0, changed N/A from a year prior.
  • Cash & Equivalents hit $31000.0 in Q4 2025 for Cavitation Technologies, up from $30000.0 in the prior quarter.
  • Over the last five years, Cash & Equivalents for CVAT hit a ceiling of $1.9 million in Q3 2021 and a floor of $7000.0 in Q4 2023.
  • Historically, Cash & Equivalents has averaged $515411.8 across 5 years, with a median of $343000.0 in 2022.
  • Biggest five-year swings in Cash & Equivalents: tumbled 97.96% in 2023 and later surged 9628.57% in 2024.
  • Tracing CVAT's Cash & Equivalents over 5 years: stood at $1.1 million in 2021, then tumbled by 68.82% to $343000.0 in 2022, then tumbled by 97.96% to $7000.0 in 2023, then surged by 9628.57% to $681000.0 in 2024, then tumbled by 95.45% to $31000.0 in 2025.
  • Business Quant data shows Cash & Equivalents for CVAT at $31000.0 in Q4 2025, $30000.0 in Q3 2025, and $249000.0 in Q2 2025.